BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 98 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $535,000 | +11.7% | 158,629 | -3.3% | 0.00% | 0.0% |
Q4 2018 | $479,000 | +112.9% | 164,060 | +349.3% | 0.00% | – |
Q3 2018 | $225,000 | -78.0% | 36,517 | -73.6% | 0.00% | -100.0% |
Q2 2018 | $1,022,000 | +527.0% | 138,493 | +458.9% | 0.00% | – |
Q1 2018 | $163,000 | -24.2% | 24,778 | -3.0% | 0.00% | – |
Q4 2017 | $215,000 | -39.4% | 25,553 | -16.8% | 0.00% | -100.0% |
Q3 2017 | $355,000 | -0.8% | 30,728 | +0.2% | 0.00% | 0.0% |
Q2 2017 | $358,000 | +23.9% | 30,668 | +31.0% | 0.00% | 0.0% |
Q1 2017 | $289,000 | -7.1% | 23,419 | +2.5% | 0.00% | 0.0% |
Q4 2016 | $311,000 | -19.8% | 22,858 | +17.3% | 0.00% | 0.0% |
Q3 2016 | $388,000 | +64.4% | 19,494 | +6.9% | 0.00% | 0.0% |
Q2 2016 | $236,000 | – | 18,233 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |